FDA approves Pfizer, German Merck immunotherapy for skin cancer – Reuters
FiercePharma |
FDA approves Pfizer, German Merck immunotherapy for skin cancer
Reuters It marks the first immunotherapy approval for the collaboration of Pfizer and Germany-based Merck, which has been playing catch-up with rivals, such as Bristol-Myers Squibb Co, Merck & Co and Roche Holding AG . "While skin cancer is one of the most … Pfizer, Merck KGaA score watershed FDA nod on cancer immunotherapy Bavencio FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell … Pfizer (PFE) and Merck (MRK) BioPharma Unit Get FDA Approval for BAVENCIO® (Avelumab), the 1st Immunotherapy … |
